Therapy of invasive bladder cancer

被引:31
作者
Dinney, CPN
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[2] Abbott Labs, Abbott Mol, Abbott Pk, IL 60064 USA
关键词
D O I
10.1016/j.urology.2006.01.043
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Effective treatment of invasive bladder cancer depends upon an understanding of the natural history of this disease and careful clinical staging. Radical cystectomy offers acceptable long-term survival for most individuals with organ-confined disease, but those with more advanced tumors or those associated with adverse features may benefit from the addition of neoadjuvant chemotherapy.
引用
收藏
页码:56 / 59
页数:4
相关论文
共 23 条
[1]
[Anonymous], DIAGNOSTIC CYTOLOGY
[2]
Cheng L, 2000, CANCER-AM CANCER SOC, V88, P2326, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2326::AID-CNCR17>3.0.CO
[3]
2-T
[4]
CordonCardo C, 1997, SEMIN SURG ONCOL, V13, P319, DOI 10.1002/(SICI)1098-2388(199709/10)13:5<319::AID-SSU5>3.0.CO
[5]
2-G
[6]
Cote RJ, 1998, CANCER RES, V58, P1090
[7]
Cote RJ, 1997, NATURE, V385, P123, DOI 10.1038/385123b0
[8]
Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer [J].
Donat, SM ;
Herr, HW ;
Bajorin, DF ;
Fair, WR ;
Sogani, PC ;
Russo, P ;
Sheinfeld, J ;
Scher, HI .
JOURNAL OF UROLOGY, 1996, 156 (02) :368-371
[9]
Correlation between annual volume of cystectomy, professional staffing, and outcomes - A statewide, population-based study [J].
Elting, LS ;
Pettaway, C ;
Bekele, BN ;
Grossman, HB ;
Cooksley, C ;
Avritscher, EBC ;
Saldin, K ;
Dinney, CPN .
CANCER, 2005, 104 (05) :975-984
[10]
ACCUMULATION OF NUCLEAR P53 AND TUMOR PROGRESSION IN BLADDER-CANCER [J].
ESRIG, D ;
ELMAJIAN, D ;
GROSHEN, S ;
FREEMAN, JA ;
STEIN, JP ;
CHEN, SC ;
NICHOLS, PW ;
SKINNER, DG ;
JONES, PA ;
COTE, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (19) :1259-1264